US Patent 7507740 Fused heterocyclic compound
Patent 7507740 was granted and assigned to Takeda Pharmaceutical Company on March, 2009 by the United States Patent and Trademark Office.
All edits
Edits on 4 Sep, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Edits on 17 Sep, 2023
Golden AI
Edits made to:
Infobox (+3 properties)
Infobox
Patent Inventor Names
Hiroshi Banno0
Masaki Seto0
Tomoyasu Ishikawa0
Edits on 15 Sep, 2023
Golden AI
Edits made to:
Article (+86 characters)
Article
Patent abstract
The present invention relates to a compound represented by the formula:
Edits on 22 Jul, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 21 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07507740 Fused heterocyclic compound US Patent 7507740 Fused heterocyclic compound
Infobox
Patent Number
075077400
Patent Number
75077400
Edits on 23 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
075077400
Date of Patent
March 24, 2009
0Patent Application Number
105928120
Date Filed
June 1, 2005
0Official Website
Patent Primary Examiner
Edits on 15 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 2 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07507740 Fused heterocyclic compound
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07507740
Date of patent
March 24, 2009
Patent application number
10592812
Date Filed
June 1, 2005
Patent primary examiner
Find more entities like US Patent 7507740 Fused heterocyclic compound
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.